"New Benefit-Risk PSUR: Impact on Benefit-Risk Assessment"

Email address:

First name:

Last name:

Job title:

Company name:

Country:

I work for

Please specify your industry *

please check before submitting

Mobile number:

What is your role?

Privacy statement »

Manage your email preferences »

Remember my details Information

Remember my details

We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

close »

Anne Wolka, Eli Lilly and Company gave the presentation "New Benefit- Risk PSUR: Impact on Benefit-Risk Assessment" at the 2014 World Drug Safety Congress Americas.

Download and learn:

The rebirth of the PSUR
Objective of the PBRER
Critical Analysis of Benefits
Critical Analysis of Risks
Integrated Benefit-Risk Analysis
Impact of the PBRER
So What Is a Structured Approach to Benefit-Risk Assessment?
Frameworks for Benefit-Risk Assessment
Focus on “The Big Picture”

"New Benefit-Risk PSUR: Impact on Benefit-Risk Assessment"

information we require

please check before submitting